According to a new study, Stonehenge might have been built somewhere else and was later shifted or transported to the place where it stands today...
A team of researchers have developed two new antibodies to treat or prevent an infection that affects infants called, pertussis.
Researchers said that pertussis is a very contagiousrespiratory tract infection that affects millions of infants in the world and also results in around 200,000 child deaths every year. The infection is commonly known as whooping cough and causes painful fits of coughing and life-threatening symptoms in infants. The disease has a devastating effect on child heath around the world.
The researchers have been working for five years to develop the new antibodies in order to treat the infection. The drugs will be used as a new anti-pertussis therapeutic injection is aimed at preventing the disease among children. The team has already conducted a pre-clinical test on animals that showed that the antibodies work as a prophylaxis to provide short-term immunity and also as a treatment to speedup recovery.
Jennifer Maynard, chemical engineer in the Cockrell School of Engineering in the US, said, “In the developing world, an estimated 200,000 babies die a year, and that's where we think we can have a really big impact. If we can get our antibodies to these high-risk infants, we could potentially prevent the infection from occurring in the first place.”
